Stockscreener 앱 받기
1.17
5.65%
-0.07
시간 외 거래:
1.15
-0.02
-1.71%
전일 마감가:
$1.24
열려 있는:
$1.27
하루 거래량:
88,905
Relative Volume:
0.72
시가총액:
$766.57K
수익:
순이익/손실:
$-13.03M
주가수익비율:
-0.00943
EPS:
-124.0371
순현금흐름:
$-6.53M
1주 성능:
-27.33%
1개월 성능:
-56.83%
6개월 성능:
-81.13%
1년 성능:
+0.00%
1일 변동 폭
$1.15
$1.27
1주일 범위
$1.15
$1.52
52주 변동 폭
$1.15
$16.92
Decoy Therapeutics Inc Stock (DCOY) Company Profile
명칭
Decoy Therapeutics Inc
전화
346-772-0346
주소
2450 HOLCOMBE BLVD, HOUSTON
Compare DCOY vs VRTX, MRNA, REGN, ARGX, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
DCOY
Decoy Therapeutics Inc
|
1.17 | 766.57K | 0 | -13.03M | -6.53M | -124.04 |
VRTX
Vertex Pharmaceuticals Inc
|
498.50 | 126.35B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
226.30 | 90.35B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
778.36 | 80.14B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
818.30 | 51.46B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
193.52 | 41.48B | 742.00K | -1.37B | -1.07B | -7.0731 |
Decoy Therapeutics Inc Stock (DCOY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-23 | 개시 | Ladenburg Thalmann | Buy |
| 2020-04-27 | 개시 | Ladenburg Thalmann | Buy |
Decoy Therapeutics Inc 주식(DCOY)의 최신 뉴스
Form S-1 Decoy Therapeutics Inc For: 8 October By Investing.com - Investing.com Canada
Decoy Therapeutics Inc (DCOY) Stockholders Plan to Sell 2.37M Sh - GuruFocus
About 10 public companies will meet investors in New York, including Decoy Therapeutics. - Stock Titan
Decoy Therapeutics Completes Warrant Inducement, Raises $3.85 Million in Gross Proceeds - Kalkine Media
Form 8K Decoy Therapeutics Inc For: 23 September By Investing.com - Investing.com Canada
Form 8K Decoy Therapeutics Inc For: 23 September By Investing.com - Investing.com India
Form 8K Decoy Therapeutics Inc For: 23 September By Investing.com - Investing.com UK
A cut from $5.91 to $3.25 brought Decoy Therapeutics (DCOY) cash, plus new rights to buy shares. - Stock Titan
DCOY Stock Volatility Spikes As Traders Track Key Levels - stockstotrade.com
Why Worthington Enterprises Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket - Benzinga
New stock-buying rights can be used immediately, Decoy says, rather than after a shareholder vote - Stock Titan
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release - PR Newswire
Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release - cherokeephoenix.org
Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules - TradingView
An investor is set to pay Decoy Therapeutics $3.85 million for shares - Stock Titan
Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-The-Market under Nasdaq Rules - PR Newswire
Curvature Securities LLC is acting as the sole placement agent in connection with this warrant inducement transaction. - nasdaq.com
DCOY Stock Slides As Cash-Rich Biotech Tests Key Support - timothysykes.com
Decoy Therapeutics shareholders approve warrant issuance and share reduction - Investing.com
Form 8K Decoy Therapeutics Inc For: 15 September By Investing.com - Investing.com Australia
Form 8K Decoy Therapeutics Inc For: 15 September By Investing.com - Investing.com India
Form 8K Decoy Therapeutics Inc For: 15 September By Investing.com - Investing.com UK
Investors approve new warrants, shrink share pool at Decoy Therapeutics (NASDAQ: DCOY) - Stock Titan
Decoy Therapeutics CEO to present antiviral dru... - Pluang
Decoy Therapeutics to Present at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference - TMX Newsfile
Decoy Therapeutics Grants 3,900 Shares to Chief Business Officer Marschel Peter Klaus - kalkinemedia.com
Decoy Therapeutics Grants 2,000 Shares to Insider Gauthier Patricia G. at No Cost on August 31, 2026 - kalkinemedia.com
Director at Decoy Therapeutics (DCOY) awarded 2,000 restricted shares vesting in 2027 - Stock Titan
Decoy Therapeutics (DCOY) awards CEO 33,455 restricted shares - Stock Titan
Decoy Therapeutics (DCOY) awards CBO stock at $0 per share - Stock Titan
Decoy Therapeutics (DCOY) CFO granted multi-year stock award - Stock Titan
Chief scientist at Decoy Therapeutics (DCOY) gets 4,216-share stock grant - Stock Titan
Decoy Therapeutics (DCOY) director gets 3,000-share stock grant - Stock Titan
Director at Decoy Therapeutics (DCOY) granted 2,000 shares vesting in 2027 - Stock Titan
Director at Decoy Therapeutics (DCOY) gets 2,000-share grant vesting in 2027 - Stock Titan
Decoy Therapeutics (DCOY) awards 3,000 $0.00 shares to director - Stock Titan
Director at Decoy Therapeutics (DCOY) granted 2,000 restricted shares - Stock Titan
Moody Capital Solutions - TMX Newsfile
Decoy (DCOY) Results Check: EPS Prints Above Forecast in the Current Update; Post-Earnings: The Stock Records a 2.81% DecreaseRevenue Guidance Range - vinanet.vn
ARMISTICE CAPITAL, LLC Acquires Shares of Decoy Therapeutics Inc (DCOY) - GuruFocus
Decoy (DCOY) Latest Quarter: The Available Earnings Metric Delivers a Beat on the Day; After Earnings: Shares Rise 0.29% in the Latest SessionRevenue Guidance Range - vinanet.vn
Decoy (DCOY) Trading Levels Update: Adds 1.14% to Close at $3.56 for the Current Session; Chart Reference - vinanet.vn
DCOY Q3 2024 Earnings: Narrower Loss of -136.8 per Share Delivers Positive SurpriseCash Flow Report - vinanet.vn
Decoy Therapeutics (DCOY) Advances 1.42% to $3.58, Holding Above SupportCTA Positioning - vinanet.vn
Armistice Capital (DCOY) discloses 65,503-share, 9.99% holding in Decoy Therapeutics - Stock Titan
Decoy Therapeutics (DCOY) Advances 1.42% to $3.58, Holding Above SupportIV Crush Alert - dars.gov.et
DCOY Q2'26 Earnings: EPS estimate is (2.88) USD - TradingView
Decoy Therapeutics: Q2 Earnings Snapshot - Barchart.com
Decoy Therapeutics: Q2 Earnings Snapshot | Associated Press | syndication news - Enidnews.com
Decoy Therapeutics: Q2 Earnings Snapshot - KING5.com
Decoy Therapeutics Inc (DCOY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Decoy Therapeutics Inc 주식 (DCOY) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| HANISH ARNOLD C | Director |
Dec 30 '25 |
Sale |
0.64 |
12 |
8 |
0 |
| HANISH ARNOLD C | Director |
Nov 20 '25 |
Buy |
0.75 |
5,000 |
3,740 |
5,015 |
| Rosenblum Mark J | Exec VP Finance, CFO |
Nov 20 '25 |
Buy |
0.80 |
20,000 |
16,000 |
20,177 |
6.10%
5.71%
자본화:
|
볼륨(24시간):